Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dementia in 2010: Paving the way for Alzheimer disease drug development.

Literature DB >> 21297645

Dementia in 2010: Paving the way for Alzheimer disease drug development.

Kaj Blennow¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2011 PMID： 21297645 DOI： 10.1038/nrneurol.2010.214

Source DB: PubMed Journal: Nat Rev Neurol ISSN： 1759-4758 Impact factor: 42.937

× No keyword cloud information.

8 in total

Review 1. Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives.

Authors: Harald Hampel; Richard Frank; Karl Broich; Stefan J Teipel; Russell G Katz; John Hardy; Karl Herholz; Arun L W Bokde; Frank Jessen; Yvonne C Hoessler; Wendy R Sanhai; Henrik Zetterberg; Janet Woodcock; Kaj Blennow
Journal: Nat Rev Drug Discov Date: 2010-07 Impact factor: 84.694

2. High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients.

Authors: Hiroaki Fukumoto; Takahiko Tokuda; Takashi Kasai; Noriko Ishigami; Hiroya Hidaka; Masaki Kondo; David Allsop; Masanori Nakagawa
Journal: FASEB J Date: 2010-03-25 Impact factor: 5.191

Review 3. Alzheimer's disease.

Authors: Kaj Blennow; Mony J de Leon; Henrik Zetterberg
Journal: Lancet Date: 2006-07-29 Impact factor: 79.321

4. 11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study.

Authors: Juha O Rinne; David J Brooks; Martin N Rossor; Nick C Fox; Roger Bullock; William E Klunk; Chester A Mathis; Kaj Blennow; Jerome Barakos; Aren A Okello; Sofia Rodriguez Martinez de Liano; Enchi Liu; Martin Koller; Keith M Gregg; Dale Schenk; Ronald Black; Michael Grundman
Journal: Lancet Neurol Date: 2010-02-26 Impact factor: 44.182

5. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory.

Authors: Ganesh M Shankar; Shaomin Li; Tapan H Mehta; Amaya Garcia-Munoz; Nina E Shepardson; Imelda Smith; Francesca M Brett; Michael A Farrell; Michael J Rowan; Cynthia A Lemere; Ciaran M Regan; Dominic M Walsh; Bernardo L Sabatini; Dennis J Selkoe
Journal: Nat Med Date: 2008-06-22 Impact factor: 53.440

6. Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease.

Authors: Gen He; Wenjie Luo; Peng Li; Christine Remmers; William J Netzer; Joseph Hendrick; Karima Bettayeb; Marc Flajolet; Fred Gorelick; Lawrence P Wennogle; Paul Greengard
Journal: Nature Date: 2010-09-02 Impact factor: 49.962

Review 7. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.

Authors: Bruno Dubois; Howard H Feldman; Claudia Jacova; Steven T Dekosky; Pascale Barberger-Gateau; Jeffrey Cummings; André Delacourte; Douglas Galasko; Serge Gauthier; Gregory Jicha; Kenichi Meguro; John O'brien; Florence Pasquier; Philippe Robert; Martin Rossor; Steven Salloway; Yaakov Stern; Pieter J Visser; Philip Scheltens
Journal: Lancet Neurol Date: 2007-08 Impact factor: 44.182

8. Revising the definition of Alzheimer's disease: a new lexicon.

Authors: Bruno Dubois; Howard H Feldman; Claudia Jacova; Jeffrey L Cummings; Steven T Dekosky; Pascale Barberger-Gateau; André Delacourte; Giovanni Frisoni; Nick C Fox; Douglas Galasko; Serge Gauthier; Harald Hampel; Gregory A Jicha; Kenichi Meguro; John O'Brien; Florence Pasquier; Philippe Robert; Martin Rossor; Steven Salloway; Marie Sarazin; Leonardo C de Souza; Yaakov Stern; Pieter J Visser; Philip Scheltens
Journal: Lancet Neurol Date: 2010-10-09 Impact factor: 44.182

8 in total

4 in total

1. Distribution of 5-ht(1E) receptors in the mammalian brain and cerebral vasculature: an immunohistochemical and pharmacological study.

Authors: M T Klein; M Teitler
Journal: Br J Pharmacol Date: 2012-06 Impact factor: 8.739